HI
NVO

Hoey Investments’s Novo Nordisk NVO Stock Holding History

Hoey Investments’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.88K Buy
81
+13
+19% +$559 ﹤0.01% 312
2026
Q1 		$2.5K Sell
68
-50
-42% -$2.37K ﹤0.01% 327
2025
Q4 		$6K Buy
118
+50
+74% +$2.56K ﹤0.01% 280
2025
Q3 		$3.77K Hold
68
– – ﹤0.01% 300
2025
Q2 		$4.69K Hold
68
– – ﹤0.01% 284
2025
Q1 		$4.72K Sell
68
-500
-88% -$41.3K ﹤0.01% 251
2024
Q4 		$48.9K Buy
568
+500
+735% +$54.1K 0.01% 134
2024
Q3 		$9.71K Hold
68
– – ﹤0.01% 206
2024
Q2 		$9.71K Hold
68
– – ﹤0.01% 206
2024
Q1 		$8.73K Hold
68
– – ﹤0.01% 214
2023
Q4 		$7.04K Hold
68
– – ﹤0.01% 229
2023
Q3 		$6.18K Hold
68
– – ﹤0.01% 237
2023
Q2 		$5.5K Hold
68
– – ﹤0.01% 246
2023
Q1 		$5.41K Buy
+68
New +$4.82K ﹤0.01% 246
2022
Q2 		– Sell
-126
Closed -$7K – 305
2022
Q1 		$7K Buy
+126
New +$6.47K ﹤0.01% 189

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

Hoey Investments's NVO Position: Q2 2026 in Review

Hoey Investments increased its Novo Nordisk (NVO) stake by 19% in Q2 2026, buying an estimated $559 and bringing the position to 81 shares worth $3.88K. The position accounts for ﹤0.01% of the portfolio, ranked #312.

Hoey Investments first reported a position in NVO in Q1 2022 and has held it in 15 quarters since. The position peaked at $48.9K in Q4 2024. 819 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Hoey Investments held 81 shares of Novo Nordisk worth $3.88K as of Q2 2026.
  • Hoey Investments bought 13 Novo Nordisk shares in Q2 2026, an estimated $559.
  • Novo Nordisk made up ﹤0.01% of Hoey Investments's portfolio in Q2 2026, its #312 holding.
  • Hoey Investments first reported a position in Novo Nordisk in Q1 2022 and has held it in 15 quarters since.
  • Hoey Investments's Novo Nordisk position peaked at $48.9K in Q4 2024.
  • 819 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Hoey Investments's 13F filing for Q2 2026, filed 27 Jul 2026.